151 related articles for article (PubMed ID: 11723233)
1. The CYP2D6 humanized mouse: effect of the human CYP2D6 transgene and HNF4alpha on the disposition of debrisoquine in the mouse.
Corchero J; Granvil CP; Akiyama TE; Hayhurst GP; Pimprale S; Feigenbaum L; Idle JR; Gonzalez FJ
Mol Pharmacol; 2001 Dec; 60(6):1260-7. PubMed ID: 11723233
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome b5 is a major determinant of human cytochrome P450 CYP2D6 and CYP3A4 activity in vivo.
Henderson CJ; McLaughlin LA; Scheer N; Stanley LA; Wolf CR
Mol Pharmacol; 2015 Apr; 87(4):733-9. PubMed ID: 25657337
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
Hayhurst GP; Lee YH; Lambert G; Ward JM; Gonzalez FJ
Mol Cell Biol; 2001 Feb; 21(4):1393-403. PubMed ID: 11158324
[TBL] [Abstract][Full Text] [Related]
4. Defective ureagenesis in mice carrying a liver-specific disruption of hepatocyte nuclear factor 4alpha (HNF4alpha ). HNF4alpha regulates ornithine transcarbamylase in vivo.
Inoue Y; Hayhurst GP; Inoue J; Mori M; Gonzalez FJ
J Biol Chem; 2002 Jul; 277(28):25257-65. PubMed ID: 11994307
[TBL] [Abstract][Full Text] [Related]
5. Human CYP2D6 and mouse CYP2Ds: organ distribution in a humanized mouse model.
Miksys SL; Cheung C; Gonzalez FJ; Tyndale RF
Drug Metab Dispos; 2005 Oct; 33(10):1495-502. PubMed ID: 16033950
[TBL] [Abstract][Full Text] [Related]
6. Sexually dimorphic P450 gene expression in liver-specific hepatocyte nuclear factor 4alpha-deficient mice.
Wiwi CA; Gupte M; Waxman DJ
Mol Endocrinol; 2004 Aug; 18(8):1975-87. PubMed ID: 15155787
[TBL] [Abstract][Full Text] [Related]
7. Contribution of hepatocyte nuclear factor-4 to down-regulation of CYP2D6 gene expression by nitric oxide.
Hara H; Adachi T
Mol Pharmacol; 2002 Jan; 61(1):194-200. PubMed ID: 11752221
[TBL] [Abstract][Full Text] [Related]
8. In vivo drug metabolism model for human cytochrome P450 enzyme using chimeric mice with humanized liver.
Katoh M; Sawada T; Soeno Y; Nakajima M; Tateno C; Yoshizato K; Yokoi T
J Pharm Sci; 2007 Feb; 96(2):428-37. PubMed ID: 17051594
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of small heterodimer partner governs cytochrome P450 (CYP) 2D6 induction during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Shen HW; Arnold SL; Yu AM; Gonzalez FJ; Isoherranen N; Jeong H
J Biol Chem; 2014 Feb; 289(6):3105-13. PubMed ID: 24318876
[TBL] [Abstract][Full Text] [Related]
10. Mutations in hepatocyte nuclear factor 4alpha (HNF4alpha) gene associated with diabetes result in greater loss of HNF4alpha function in pancreatic beta-cells than in nonpancreatic beta-cells and in reduced activation of the apolipoprotein CIII promoter in hepatic cells.
Oxombre B; Moerman E; Eeckhoute J; Formstecher P; Laine B
J Mol Med (Berl); 2002 Jul; 80(7):423-30. PubMed ID: 12110948
[TBL] [Abstract][Full Text] [Related]
11. The orphan nuclear receptor HNF4alpha determines PXR- and CAR-mediated xenobiotic induction of CYP3A4.
Tirona RG; Lee W; Leake BF; Lan LB; Cline CB; Lamba V; Parviz F; Duncan SA; Inoue Y; Gonzalez FJ; Schuetz EG; Kim RB
Nat Med; 2003 Feb; 9(2):220-4. PubMed ID: 12514743
[TBL] [Abstract][Full Text] [Related]
12. Hepatocyte nuclear factor 4alpha is a central regulator of bile acid conjugation.
Inoue Y; Yu AM; Inoue J; Gonzalez FJ
J Biol Chem; 2004 Jan; 279(4):2480-9. PubMed ID: 14583614
[TBL] [Abstract][Full Text] [Related]
13. Critical role of charged residues in helix 7 of the ligand binding domain in Hepatocyte Nuclear Factor 4alpha dimerisation and transcriptional activity.
Eeckhoute J; Oxombre B; Formstecher P; Lefebvre P; Laine B
Nucleic Acids Res; 2003 Nov; 31(22):6640-50. PubMed ID: 14602925
[TBL] [Abstract][Full Text] [Related]
14. Disposition of debrisoquine in Caucasians with different CYP2D6-genotypes including those with multiple genes.
Dalén P; Dahl ML; Eichelbaum M; Bertilsson L; Wilkinson GR
Pharmacogenetics; 1999 Dec; 9(6):697-706. PubMed ID: 10634132
[TBL] [Abstract][Full Text] [Related]
15. Analysis of protein dimerization and ligand binding of orphan receptor HNF4alpha.
Bogan AA; Dallas-Yang Q; Ruse MD; Maeda Y; Jiang G; Nepomuceno L; Scanlan TS; Cohen FE; Sladek FM
J Mol Biol; 2000 Sep; 302(4):831-51. PubMed ID: 10993727
[TBL] [Abstract][Full Text] [Related]
16. Krüppel-like factor 9 promotes hepatic cytochrome P450 2D6 expression during pregnancy in CYP2D6-humanized mice.
Koh KH; Pan X; Zhang W; McLachlan A; Urrutia R; Jeong H
Mol Pharmacol; 2014 Dec; 86(6):727-35. PubMed ID: 25217496
[TBL] [Abstract][Full Text] [Related]
17. High-Fat Diet Feeding Alters Expression of Hepatic Drug-Metabolizing Enzymes in Mice.
Ning M; Jeong H
Drug Metab Dispos; 2017 Jul; 45(7):707-711. PubMed ID: 28442500
[TBL] [Abstract][Full Text] [Related]
18. Regulation of hepatic fasting response by PPARgamma coactivator-1alpha (PGC-1): requirement for hepatocyte nuclear factor 4alpha in gluconeogenesis.
Rhee J; Inoue Y; Yoon JC; Puigserver P; Fan M; Gonzalez FJ; Spiegelman BM
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4012-7. PubMed ID: 12651943
[TBL] [Abstract][Full Text] [Related]
19. Polymorphic cytochrome P450 2D6: humanized mouse model and endogenous substrates.
Yu AM; Idle JR; Gonzalez FJ
Drug Metab Rev; 2004 May; 36(2):243-77. PubMed ID: 15237854
[TBL] [Abstract][Full Text] [Related]
20. Maturity-onset diabetes of the young Type 1 (MODY1)-associated mutations R154X and E276Q in hepatocyte nuclear factor 4alpha (HNF4alpha) gene impair recruitment of p300, a key transcriptional co-activator.
Eeckhoute J; Formstecher P; Laine B
Mol Endocrinol; 2001 Jul; 15(7):1200-10. PubMed ID: 11435618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
